Mantle Cell Lymphoma Therapeutics
Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with curre ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-thrombin III Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Diagnosis of antithrombin deficiency 1.2.3 Activity assays 1.2.4 Immunological assays 1.3 Market by Application 1.3.1 Global Anti-thrombin III Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Research institute 1.3.4 Clinic 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-thrombin III Testing Market Perspective (2016-2027) 2.2 Anti-thrombin III Testing Growth Trends by Regions 2.2.1 Anti-thrombin III Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti-thrombin III Testing Historic Market Share by Regions (2016-2021) 2.2.3 Anti-thrombin III Testing Forecasted Market Size by Regions (2022-2027) 2.3 Anti-thrombin III Testing Industry Dynamic 2.3.1 Anti-thrombin III Testing Market Trends 2.3.2 Anti-thrombin III Testing Market Drivers 2.3.3 Anti-thrombin III Testing Market Challenges 2.3.4 Anti-thrombin III Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-thrombin III Testing Players by Revenue 3.1.1 Global Top Anti-thrombin III Testing Players by Revenue (2016-2021) 3.1.2 Global Anti-thrombin III Testing Revenue Market Share by Players (2016-2021) 3.2 Global Anti-thrombin III Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti-thrombin III Testing Revenue 3.4 Global Anti-thrombin III Testing Market Concentration Ratio 3.4.1 Global Anti-thrombin III Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-thrombin III Testing Revenue in 2020 3.5 Anti-thrombin III Testing Key Players Head office and Area Served 3.6 Key Players Anti-thrombin III Testing Product Solution and Service 3.7 Date of Enter into Anti-thrombin III Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-thrombin III Testing Breakdown Data by Type 4.1 Global Anti-thrombin III Testing Historic Market Size by Type (2016-2021) 4.2 Global Anti-thrombin III Testing Forecasted Market Size by Type (2022-2027) 5 Anti-thrombin III Testing Breakdown Data by Application 5.1 Global Anti-thrombin III Testing Historic Market Size by Application (2016-2021) 5.2 Global Anti-thrombin III Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti-thrombin III Testing Market Size (2016-2027) 6.2 North America Anti-thrombin III Testing Market Size by Type 6.2.1 North America Anti-thrombin III Testing Market Size by Type (2016-2021) 6.2.2 North America Anti-thrombin III Testing Market Size by Type (2022-2027) 6.2.3 North America Anti-thrombin III Testing Market Size by Type (2016-2027) 6.3 North America Anti-thrombin III Testing Market Size by Application 6.3.1 North America Anti-thrombin III Testing Market Size by Application (2016-2021) 6.3.2 North America Anti-thrombin III Testing Market Size by Application (2022-2027) 6.3.3 North America Anti-thrombin III Testing Market Size by Application (2016-2027) 6.4 North America Anti-thrombin III Testing Market Size by Country 6.4.1 North America Anti-thrombin III Testing Market Size by Country (2016-2021) 6.4.2 North America Anti-thrombin III Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti-thrombin III Testing Market Size (2016-2027) 7.2 Europe Anti-thrombin III Testing Market Size by Type 7.2.1 Europe Anti-thrombin III Testing Market Size by Type (2016-2021) 7.2.2 Europe Anti-thrombin III Testing Market Size by Type (2022-2027) 7.2.3 Europe Anti-thrombin III Testing Market Size by Type (2016-2027) 7.3 Europe Anti-thrombin III Testing Market Size by Application 7.3.1 Europe Anti-thrombin III Testing Market Size by Application (2016-2021) 7.3.2 Europe Anti-thrombin III Testing Market Size by Application (2022-2027) 7.3.3 Europe Anti-thrombin III Testing Market Size by Application (2016-2027) 7.4 Europe Anti-thrombin III Testing Market Size by Country 7.4.1 Europe Anti-thrombin III Testing Market Size by Country (2016-2021) 7.4.2 Europe Anti-thrombin III Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti-thrombin III Testing Market Size (2016-2027) 8.2 Asia-Pacific Anti-thrombin III Testing Market Size by Type 8.2.1 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti-thrombin III Testing Market Size by Application 8.3.1 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti-thrombin III Testing Market Size by Region 8.4.1 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti-thrombin III Testing Market Size (2016-2027) 9.2 Latin America Anti-thrombin III Testing Market Size by Type 9.2.1 Latin America Anti-thrombin III Testing Market Size by Type (2016-2021) 9.2.2 Latin America Anti-thrombin III Testing Market Size by Type (2022-2027) 9.2.3 Latin America Anti-thrombin III Testing Market Size by Type (2016-2027) 9.3 Latin America Anti-thrombin III Testing Market Size by Application 9.3.1 Latin America Anti-thrombin III Testing Market Size by Application (2016-2021) 9.3.2 Latin America Anti-thrombin III Testing Market Size by Application (2022-2027) 9.3.3 Latin America Anti-thrombin III Testing Market Size by Application (2016-2027) 9.4 Latin America Anti-thrombin III Testing Market Size by Country 9.4.1 Latin America Anti-thrombin III Testing Market Size by Country (2016-2021) 9.4.2 Latin America Anti-thrombin III Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-thrombin III Testing Market Size (2016-2027) 10.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type 10.2.1 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application 10.3.1 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti-thrombin III Testing Market Size by Country 10.4.1 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Anti-thrombin III Testing Introduction 11.1.4 Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 Danaher Corp. 11.2.1 Danaher Corp. Company Details 11.2.2 Danaher Corp. Business Overview 11.2.3 Danaher Corp. Anti-thrombin III Testing Introduction 11.2.4 Danaher Corp. Revenue in Anti-thrombin III Testing Business (2016-2021) 11.2.5 Danaher Corp. Recent Development 11.3 F. Hoffmann-La Roche Ltd. 11.3.1 F. Hoffmann-La Roche Ltd. Company Details 11.3.2 F. Hoffmann-La Roche Ltd. Business Overview 11.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Introduction 11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2016-2021) 11.3.5 F. Hoffmann-La Roche Ltd. Recent Development 11.4 Siemens Healthcare GmbH 11.4.1 Siemens Healthcare GmbH Company Details 11.4.2 Siemens Healthcare GmbH Business Overview 11.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Introduction 11.4.4 Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2016-2021) 11.4.5 Siemens Healthcare GmbH Recent Development 11.5 Thermo Fisher Scientific Inc. 11.5.1 Thermo Fisher Scientific Inc. Company Details 11.5.2 Thermo Fisher Scientific Inc. Business Overview 11.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Introduction 11.5.4 Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2016-2021) 11.5.5 Thermo Fisher Scientific Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Anti-thrombin III Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Diagnosis of antithrombin deficiency Table 3. Key Players of Activity assays Table 4. Key Players of Immunological assays Table 5. Global Anti-thrombin III Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Anti-thrombin III Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Anti-thrombin III Testing Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Anti-thrombin III Testing Market Share by Regions (2016-2021) Table 9. Global Anti-thrombin III Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Anti-thrombin III Testing Market Share by Regions (2022-2027) Table 11. Anti-thrombin III Testing Market Trends Table 12. Anti-thrombin III Testing Market Drivers Table 13. Anti-thrombin III Testing Market Challenges Table 14. Anti-thrombin III Testing Market Restraints Table 15. Global Anti-thrombin III Testing Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Anti-thrombin III Testing Market Share by Players (2016-2021) Table 17. Global Top Anti-thrombin III Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2020) Table 18. Ranking of Global Top Anti-thrombin III Testing Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Anti-thrombin III Testing Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Anti-thrombin III Testing Product Solution and Service Table 22. Date of Enter into Anti-thrombin III Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million) Table 25. Global Anti-thrombin III Testing Revenue Market Share by Type (2016-2021) Table 26. Global Anti-thrombin III Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Anti-thrombin III Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Anti-thrombin III Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Anti-thrombin III Testing Revenue Market Share by Application (2016-2021) Table 30. Global Anti-thrombin III Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Anti-thrombin III Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million) Table 33. North America Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million) Table 35. North America Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Anti-thrombin III Testing Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Anti-thrombin III Testing Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbott Laboratories Company Details Table 63. Abbott Laboratories Business Overview Table 64. Abbott Laboratories Anti-thrombin III Testing Product Table 65. Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million) Table 66. Abbott Laboratories Recent Development Table 67. Danaher Corp. Company Details Table 68. Danaher Corp. Business Overview Table 69. Danaher Corp. Anti-thrombin III Testing Product Table 70. Danaher Corp. Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million) Table 71. Danaher Corp. Recent Development Table 72. F. Hoffmann-La Roche Ltd. Company Details Table 73. F. Hoffmann-La Roche Ltd. Business Overview Table 74. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Product Table 75. F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million) Table 76. F. Hoffmann-La Roche Ltd. Recent Development Table 77. Siemens Healthcare GmbH Company Details Table 78. Siemens Healthcare GmbH Business Overview Table 79. Siemens Healthcare GmbH Anti-thrombin III Testing Product Table 80. Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million) Table 81. Siemens Healthcare GmbH Recent Development Table 82. Thermo Fisher Scientific Inc. Company Details Table 83. Thermo Fisher Scientific Inc. Business Overview Table 84. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Product Table 85. Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million) Table 86. Thermo Fisher Scientific Inc. Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-thrombin III Testing Market Share by Type: 2020 VS 2027 Figure 2. Diagnosis of antithrombin deficiency Features Figure 3. Activity assays Features Figure 4. Immunological assays Features Figure 5. Global Anti-thrombin III Testing Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Research institute Case Studies Figure 8. Clinic Case Studies Figure 9. Other Case Studies Figure 10. Anti-thrombin III Testing Report Years Considered Figure 11. Global Anti-thrombin III Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Anti-thrombin III Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Anti-thrombin III Testing Market Share by Regions: 2020 VS 2027 Figure 14. Global Anti-thrombin III Testing Market Share by Regions (2022-2027) Figure 15. Global Anti-thrombin III Testing Market Share by Players in 2020 Figure 16. Global Top Anti-thrombin III Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Anti-thrombin III Testing Revenue in 2020 Figure 18. Global Anti-thrombin III Testing Revenue Market Share by Type (2016-2021) Figure 19. Global Anti-thrombin III Testing Revenue Market Share by Type (2022-2027) Figure 20. North America Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Anti-thrombin III Testing Market Share by Type (2016-2027) Figure 22. North America Anti-thrombin III Testing Market Share by Application (2016-2027) Figure 23. North America Anti-thrombin III Testing Market Share by Country (2016-2027) Figure 24. United States Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Anti-thrombin III Testing Market Share by Type (2016-2027) Figure 28. Europe Anti-thrombin III Testing Market Share by Application (2016-2027) Figure 29. Europe Anti-thrombin III Testing Market Share by Country (2016-2027) Figure 30. Germany Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Anti-thrombin III Testing Market Share by Type (2016-2027) Figure 38. Asia-Pacific Anti-thrombin III Testing Market Share by Application (2016-2027) Figure 39. Asia-Pacific Anti-thrombin III Testing Market Share by Region (2016-2027) Figure 40. China Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Anti-thrombin III Testing Market Share by Type (2016-2027) Figure 48. Latin America Anti-thrombin III Testing Market Share by Application (2016-2027) Figure 49. Latin America Anti-thrombin III Testing Market Share by Country (2016-2027) Figure 50. Mexico Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Anti-thrombin III Testing Market Share by Type (2016-2027) Figure 54. Middle East & Africa Anti-thrombin III Testing Market Share by Application (2016-2027) Figure 55. Middle East & Africa Anti-thrombin III Testing Market Share by Country (2016-2027) Figure 56. Turkey Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Abbott Laboratories Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021) Figure 60. Danaher Corp. Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021) Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021) Figure 62. Siemens Healthcare GmbH Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021) Figure 63. Thermo Fisher Scientific Inc. Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed
Abbott Laboratories Danaher Corp. F. Hoffmann-La Roche Ltd. Siemens Healthcare GmbH Thermo Fisher Scientific Inc.
Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with curre ... Read More
Strict regulatory norms and increasing emphasis on developing safer vehicles have boosted the ado ... Read More
Vendors are making constant improvements in automotive steering systems by adding advanced featur ... Read More
The emergence of leading-edge autonomous driving technologies and mobility-as-a-service (MaaS), a ... Read More